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Abstract
Background and Objective: It was hypothesized that within an invasively treated group and within a group that improved in angina
pectoris no difference in effect size would occur between prospective and retrospective measures. Furthermore, it was hypothesized that
assessment of perceived change at post-test may be invalid because of recall bias and present-state bias.
Study Design and Setting: Effect sizes (as standardized response means) were used as indicators of magnitude of change. Linear struc-
tural equation analysis (with LISREL) was used to investigate the relationship between the estimates of recall accuracy and retrospectively
assessed change.
Results: No significant differences were found between prospective and retrospective measures of change over time in health-related
functional status. Recall bias was not associated with retrospective measurement of change within a 12-week interval. An expected present-
state effect was found in a structural equation model.
Conclusion: Prospective and retrospective indices of magnitude of change were similar between groups receiving treatment of known
efficacy. Recall bias seems to be an acceptable risk in short-term follow-up studies.  2006 Elsevier Inc. All rights reserved.
Keywords: Health status indicators; Responsiveness; Prospective change; Heart failure; Retrospective change; Clinically relevant change; Effect size;
Recall bias; Present-state bias1. Introduction
The measurement of treatment-related change over a pe-
riod of time in patients is central to both clinical research
and practice. In evaluation research, investigators commonly
define change as the difference between baseline and
post-treatment scores, obtained from serial measurements
(i.e., serial change). In clinical practice, however, change
after treatment is generally assessed retrospectively by ask-
ing the patient to give an appraisal of the magnitude and
direction of the change in health status or functioning as
stable, improved, or deteriorated. In the interaction between
clinician and patient, such a retrospective appraisal by the
* Corresponding author. Tel.:131-50-3636504; fax:131-50-3633059.
E-mail address: b.middel@med.rug.nl (B. Middel).0895-4356/06/$ – see front matter  2006 Elsevier Inc. All rights reserved.
doi: 10.1016/j.jclinepi.2005.08.018patient and physician concerning several domains of the
health status has clinical relevance, in that it determines
the decisions made in the management of the disease.
This is common practice, and therefore consideration must
be given to the possibility of measuring the retrospective
change directly in evaluation studies of treatment efficacy
with, for example, health-related functional status (HRFS)
as the outcome.
In evaluation research, retrospective measurement is
obviously easier and more economical than serial measure-
ment. Despite the apparent advantages of retrospective
measurement of change in HRFS, there is a suspicion that
global or transition questions are biased due to recall prob-
lems or present-state effects at follow-up. It is assumed that
prospective or serial change assessed by repeated measure-
ment is superior and that the use of retrospective assess-
ment of change in HFRS with global or transition
questions is definitely not advisable [1].
504 B. Middel et al. / Journal of Clinical Epidemiology 59 (2006) 503–511There is, however, an ongoing debate about the methods
for estimating clinically relevant change [2–5]. One of the
assumptions in this debate is that changes inferred from re-
peated measurement approximate the change captured by
the patient’s retrospective perceptions of change over a pe-
riod of time [6–8]. Other researchers, however, have found
that the retrospective recall of a change in health status or
symptoms is not as accurate as the change found in pre–
post designs because of the complexity of the question.
For example, when an interviewer asks patients who have
undergone a coronary artery bypass grafting (CABG) oper-
ation whether they have felt better or worse since the by-
pass operation, the patients have first to make a judgment
of the present state of health, then make a reconstruction
of the situation before the CABG, and finally do mental
subtraction to estimate the perceived direction and amount
of change over time.
This method has some weaknesses. First, there is often
a correlation between the ‘present state’ score, the post-
treatment score, and the ‘retrospectively perceived change’
score in that health status domain [9], because this post-
treatment present state is the frame of reference for the
comparison with the health status before the treatmentd
this is present-state bias. A second weakness is that when
the time span is too long, people have great difficulty re-
membering how they were before treatmentdthis is recall
bias. A third problem is that retrospective assessment of
treatment-related change may be invalid if patients feel that
they are being prevented from living as they would like to
by problems not related to the disease for which they are
being treated.
The fourth weakness is that patients who remained sta-
ble after an invasive operation (e.g., CABG), according to
the outcome of repeated measurement, were obviously in
some respects limited in functional status before this treat-
ment, and consequently when posed a retrospective global
question were likely to report improvement. Some transi-
tion items are too general (e.g., ‘‘Have you felt better or
worse since your bypass-operation?’’). The patient may
then refer only to a few symptoms manifesting themselves
at that particular point in time, such as shortness of breath,
pain in the chest, or fatigue [10–13]. Additionally, the sin-
gle item is a relatively coarse method in comparison with
the multi-item scale and is not as suitable for detecting
the minor differences in health perception that may still
be clinically relevant.
In the present study, multiple-item transition scales en-
able patients to rate the extent to which they have changed
regarding a number of disease-specific variables, thereby
allowing for the possibility that not all aspects of function-
ing, health status and symptoms will be given the same re-
sponse. A scale constructed from the summed composite of
transition items (transition scales) that belong to a HRFS
domaindfor example, physical, emotional, or social func-
tioningdyields more information reflecting meaningful
change in that dimension than single items would.Furthermore, the comparison of these retrospective change
scales with multiple serial change scales, comprising iden-
tical items in terms of responsiveness, may contribute to the
analysis of the convergent validity of prospective and retro-
spective measures of change in HRFS. In the present study,
the importance or value that patients assign to their
perceived change after treatment was used to weight the
change in HRFS-scores-weighted items.
In an earlier publication based on the data from the pres-
ent study [8], we showed that the serial change scores of
items, and likewise the identical transition items of the
physical functioning scale, yielded similar factor loadings
and estimated internal consistency coefficients (Cronbach’s
a), despite the weaknesses of retrospective global ques-
tions. The results published by Aseltine et al. [14] correlate
with our findings that no significant differences in respon-
siveness (standardized response mean: SRM) were ob-
served between serial change scales and transition scales
[8,15]. We therefore hypothesize that retrospective assess-
ment of treatment-related change over time may not be af-
fected by recall bias in short-term evaluation of medical
treatment or interventions of approximately 6 weeks before
and 12 weeks after a significant event or intervention such
as percutaneous transluminal coronary angioplasty (PTCA)
or CABG, and may be a valid and reliable proxy for serial
change assessment with an HRFS measure.
The present study, however, explores the relationship be-
tween serial measurement and weighted or unweighted ret-
rospective measurement, with identical items and scales
belonging to the physical and emotional domains of
health-related functional status. The patients in the present
study were undergoing treatment that is known to have an
impact on health status domains, and therefore the indices
used should reflect meaningful change between baseline
and follow-up.
The following questions were addressed in the present
study:
1. Are responsiveness indices derived from serial
change scores and from weighted and unweighted
retrospective scores similar when patients are broken
down into groups with known treatment efficacy?
2. To what extent is retrospective measurement using
global questions influenced by recall bias?
2. Methods
2.1. Patient selection
To ensure that a change in health status manifested itself,
we selected a group of patients undergoing treatment with
a known efficacy and selected a disease-specific instrument
with a known sensitivity to detect change over time [16].
The instrument had proved to be sensitive to change in
a similar sample of Dutch patients with ischemic heart
disease [17].
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consecutively from three hospitals in the north of the
Netherlands. All the subjects were patients who, following
a coronary angiography, were scheduled for PTCA or
CABG, or who needed no operative intervention but re-
ceived medication. Patients with other incapacitating dis-
eases, cognitive impairments, aged 75 years or older, or
who did not speak Dutch were excluded from the study.
Ethical approval was obtained from the ethics committee
at each participating hospital.
All participating patients received a mailed question-
naire accompanied by a written informed consent form.
The questionnaire was prospectively administered at the
baseline and 12 weeks after the decision for noninvasive in-
tervention, or 12 weeks after the day of the PTCA/CABG
intervention. We presumed that at baseline (and thus prior
to the coronary angiography) both patients and cardiolo-
gists had no information about the subsequent decision con-
cerning either intervention, and that this would therefore
not affect the health status assessment and should reduce
the risk of floor and ceiling effects. This control for poten-
tial bias resulted in logistical problems, however, and 6
months after the start of the study we were forced to select
patients already waiting for outpatient treatment (PTCA) or
waiting for hospital admission (CABG), shortly after the
decision had already been taken by the cardiologists. The
average time between baseline assessment and follow-up
after CABG and PTCA was 15 weeks.
2.2. Measures
The Minnesota Living with Heart Failure Questionnaire
(MLHF-Q) [18] is a disease-specific instrument that origi-
nally comprised 21 items. Two scales measure the physical
functioning dimension (8 items), the emotional functioning
dimension (5 items) and the overall score reflects health-
related quality of life (21 items). In a previous Dutch
sample [17], one item from the MLHF-Q had no correlation
with the physical functioning factor as predefined by Rector
and Cohn [18]. This also occurred in the present study [8],
and so the item was not used in further analysis. Conse-
quently, in the present study only the seven items for phys-
ical functioning and the five items for emotional
functioning scales from the MLHF-Q were used. Eight sep-
arate MLHF-Q items were omitted in this methodological
evaluation of serially and retrospectively assessed change
in HRFS domains, because they consist of a heterogeneous
set of social, financial, medical, and economic limitations.
To investigate the concordance between serial change and
perceived extent of change in HRFS domains, we extended
the questionnaire with three items from the MOS-20 [19]
physical functioning scale. These results have been re-
ported elsewhere [5,8]. The response options were analo-
gous to the MLHF-Q questionnaire’s format (Fig. 1).
The physical dimension subscale has a range from 0 to
35 and the emotional dimension subscale from 0 to 25.The total score of the MOS-20 items assessing physical
functioning ranges from 0 to 15. Consequently, the total
scores of the physical functioning scale used in the present
study range between 0 and 50. A higher score indicates
a high negative impact of heart disease in the assessed
aspects.
Scores of serial change items (SCI) were calculated by
subtracting the follow-up score from the baseline score. A
serial change score of zero was considered to indicate nei-
ther improvement nor deterioration and a high serial change
score was indicative of a high degree of improvement.
To assess change in the same health domain using
a straightforward method, we modified each item from
the repeatedly assessed baseline questionnaire into direct
questions of perceived change using global or transition
questions [20]. Patients separately rated 15 items from
the MLHF-Q and MOS-20 for perceived magnitude of
change (PMC) and for the importance of that particular
change in physical and emotional functioning in relation
to their treatment.
The perceived magnitude of change questionnaire
(Fig. 1) was used to classify patients according to whether
they had improved, deteriorated, or perceived no change
regarding each item of the questionnaire belonging to the
dimensions of physical and emotional functioning. Patients
who had undergone CABG or PTCA were asked, ‘‘Since
my operation, my problems with walking or climbing stairs
in relation to my heart failure have become. ’’; patients
who had received medication were asked, ‘‘Since the last
time I filled out the questionnaire, my problems with.have
become. ’’ (and so on).
PMC was assessed after treatment at follow-up with
these response categories: (1) increased greatly, (2) moder-
ately increased, (3) increased a little, (4) has not changed,
(5) decreased a little, (6) decreased moderately, and (7) de-
creased greatly. High scores in the transition scales indicate
a high degree of improvement.
The estimated importance (I ) of the perceived magni-
tude of change was elicited for each item with a 10-cm
visual analog scale with anchors from ‘least important’
(rating 5 1) to ‘extremely important’ (rating 5 10). The
individual patient ratings of perceived magnitude of change
(PMCi) and individual importance (Ii) for each HRFS item
were multiplied together to form a weighted magnitude-
importance score for each item (WPMCi).
To give meaning to ‘no change’ in the calculation of the
WPMCi, the PMCi item’s original seven-point scores were
expressed as deviations from ‘no change’ (score 4) by sub-
tracting four points from each score : 23 5 deteriorated
greatly, 22 5 deteriorated moderately, 21 5 deteriorated
a little, 05 no change, 15 improved a little, 25 improved
moderately, and 3 5 improved greatly.
The total score for the patient’s weighted magnitude of
change-importance item scores was calculated by S(PMCi
3 Ii). For each patient, a maximum possible score was cal-
culated as the sum of the importance ratings (Ii) multiplied
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Did your heart failure prevent you from living as you wanted  during the last month by making it difficult for you to  
…
            NO VERY LITTLE      VERY MUCH
MLHF-Q (physical scale): 
         …  walk about or to climb stairs   
MLHF-Q (emotional scale): 
         …  conc
 MOS-20 items in MLHF-Q format:  
 … bend, stoop, or lift light objects? 
 
 … run at a fast pace?    
Global questions 
Did your heart failure prevent you from living as you wanted during the last month because of 
        …  Physical complaints                                         0  1 2 3 4 5 
        …  Pain in the chest                                              0  1 2 3 4 5 
 Perceived Magnitude of Change (PMCi)
 Since the last questionnaire, my problems with walking about or climbing stairs have … 
0 increased greatly unimportant 
0 increased              
0 increased a little 
0 not changed 
0 decreased a little          unimportant                                  
                                                                     extremely important 
extremely important 
0 decreased  
0 decreased greatly 
        0  1 2 3 4 5 
entrate or remember things                    0  1 2 3 4 5 
          0  1 2 3 4 5 
… lift heavy objects, like moving a table?         0 1 2 3 4 5 
         0  1 2 3 4 5 
Fig. 1. Examples of questionnaire items.by the maximum perceived magnitude of change score
(PMC 5 3).
The final patient-specific index (PSI) for each patient
was estimated, following Wright and Young [21], as the ra-
tio of the total sum of magnitudedthat is, the importance
scores divided by the maximum possible score times 100:
PSI5
PðPMCi3 IiÞP ð33 IiÞ 3100
To assess recall bias, the follow-up questionnaire con-
tained two items asking patients to recall the extent to
which they felt limited by physical problems or by pain
due to their heart failure. The questions were introduced
as follows: ‘‘If you were to assess your limitations due to
pain before the operation (CABG/PTCA group), or since
the first questionnaire you filled out some 12 weeks ago
in the medication group, what would be your estimation?’’The items were phrased as follows: ‘‘Before my operation,
or at the first time I filled out the questionnaire, I was pre-
vented from living as I wanted to because of the pain in my
chest’’ or ‘‘.because of physical complaints.’’ The re-
sponse options ranged from ‘no’ (score 5 0) and ‘very lit-
tle’ (score 5 1) to ‘greatly’ (score 5 5) and were presented
in the same format as the corresponding global question at
baseline, phrased in the present tense (Fig. 1).
Subtraction of the item’s score from the patient’s score
at baseline was used as an estimate of recall bias. The ex-
tent of deviation ranged from –5 to 5: a zero score indicates
no recall bias and a score of absolute value 5 (i.e., either
negative or positive) indicates the maximum amount of
recall bias. Such a score of 5 indicates that the estimates
made by the patient at 12-week follow-up regarding the ex-
tent of limitation before treatment, and the estimate actually
given at baseline, were completely the opposite of each
other.
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To make comparisons between the responsiveness of se-
rial change scales (SCS), unweighted PMC items (UPMC),
weighted WPMC items, and the summed PSI, responsive-
ness was quantified by means of SRM. The effect size of
the serial measurement was calculated as the mean change
in the measurements for the group divided by the standard
deviation (SD) of the change scores of all the patients:
SRM 5 D/SDD. For weighted and unweighted measures
of perceived magnitude of change, responsiveness was con-
sidered to be the mean difference between no change divid-
ed by the SD of the difference, as previously reported by
Fischer et al. [1]. Because ‘no change’ was scored as a zero
for all the questions, it was simply calculated as the mean
score measure for every group of patients divided by the
SD of the measure for all patients. A higher SRM for a mea-
sure in a group with improved health-related quality of life
indicates a greater ability of the instrument to detect a shift
from the baseline.
A path model was analyzed to test the estimates of the
magnitude of the effects of present-state bias and recall bias
on retrospectively perceived change, and to estimate
whether our data fit the proposed model. The analysis
was performed with structural equation modeling using
the maximum likelihood method (LISREL version 8.54)
[22]. Residual correlations between physical health at base-
line and follow-up and between serial change and recall bi-
as were allowed, because standardized residuals indicated
this correlation to exist. To allow for mutual comparisons
between the path coefficients, the completely standardized
solution was used. The fit of the model was evaluated by
means of the comparative fit index (CFI) and the standard-
ized root mean square residual (SRMR), in addition to the
chi-square (c2) test. An adequate fit of the model is indic-
ated by CFI > .95, and SRMR ! .08 [23].
3. Results
3.1. Sample
A total of 398 candidates were screened for inclusion in
the present study; 139 (35%) did not return the first question-
naire, so the final sample consisted of 259 patients. The prob-
ability of systematic differences between nonresponders and
the study sample could not be tested, because no information
was available without the written informed consent of the
patients who did not return the first questionnaire.
Forty-two patients (16%) dropped out of the study be-
fore the follow-up assessment because of the death of the
patient (n 5 7) or because the patient had no heart failure
(n 5 9), refused further participation (n 5 9), was too ill at
follow-up (n5 3), had moved (n5 3), or did not react at all
(n 5 11). To ensure that the patients who dropped out at
follow-up did not deviate systematically from the study
group, the characteristics of these patients at the time theyreturned the first questionnaire were compared with the
baseline characteristics of those who completed the ques-
tionnaire at follow-up. Demographic characteristics of the
two groups were similar, except that the study sample
had a statistically significant higher level of education
(c2 5 14.70, P ! .05). This comparison also showed that
there were no significant differences in the mean scores
in the baseline health-status scales. Analyses were based
on the 217 subjects who filled in the questionnaires at base-
line and post-test.
The mean age of the patients was 60.6 years (SD 5
9.43), with a range from 25 to 75. The gender breakdown
was 61 female and 156 male. More men than women had
a partner (92% vs. 72%), a higher education (18% vs.
7%), and employment (36% vs. 7%). At follow-up, 29%
had undergone a CABG, 33% had a PTCA, and 38% had
received pharmacotherapy. These and other characteristics
are presented in Table 1.
3.2. Known groups validity
The comparison of serial change scales (SCS) with per-
ceived magnitude of change (PMC), weighted perceived
magnitude of change (WPMC), and PSI showed no differ-
ences in responsiveness estimates in the present study.
It was hypothesized that if a distinction between invasive
and noninvasive treatment and between improvement and
stability in angina pectoris was made, differences in the
Table 1
Sociodemographic characteristics of patients receiving three different








Partner, not cohabiting 2 (1)
Unmarried 6 (3)
Divorced 8 (4)
Widow or widower 16 (7)
Employment status
Employed 57 (26)
Unemployed or retired 147 (68)
Education
Grade 6 44 (20)
Technical school (grades 7–9) 61 (28)
Junior high school (grades 7–9) 34 (16)
Junior high school including vocational education 33 (15)
High school or A levels 6 (3)
College (undergraduate study, 4 years) 22 (10)





Abbreviations: CABG, coronary artery bypass grafting; PTCA,
percutaneous transluminal coronary angioplasty.
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groups. Invasive PTCA or CABG treatments were expected
to produce more change, and noninvasive treatment was ex-
pected to produce very little change in HRFS over a period
of time. From our responsiveness analysis (Table 2), the
SRM of the physical function scale was .73 for SCS scores,
.78 for PMC scales, and .75 for the WPMC scales. The PSI
scores yielded the highest responsiveness index, .88. In the
group of patients who improved in angina-related chest
pain, effect sizes of the physical functioning scales were
higher than in the invasively treated group, and in both
groups an identical trend was reflected. The confidence in-
tervals (95% CI) showed no overlap, indicating statistically
significant different effect sizes between the invasively trea-
ted vs. noninvasively treated patients and significant differ-
ent effect sizes between improved angina pectoris patients
vs. stable patients. The SRMs of the SCS, PMC, and
WPMC scales of emotional function in the invasively trea-
ted group ranged from .36 to .39 and the PSI emotional
functioning scale yielded the highest effect size, .53.
The group of patients showing an improvement in
angina-related chest pain showed larger effect sizes in the
emotional functioning scales than the group treated with
PTCA or CABG. The PSI again yielded the highest effect
size. No differences were found between the SRMs from
PMC and WPMC scales within each group compared to
the SCS in both dimensions. As hypothesized, greater mag-
nitude of change was found in the invasive treatment group.
This was also the case in the group showing improvements
in angina pectoris for SCS, PMC, WPMC, and PSI scales of
physical and emotional functioning when compared to the
noninvasively treated and stable groups, respectively. Fur-
thermore, the SRM indices of the emotional functioning
scale showed similar results, although smaller in magnitude.
3.3. Recall bias and present-state bias of change in
health reevaluation
In the path model (Fig. 2), the following latent variables
were used in the analysis: (1) the perceived magnitude ofa change (PMC) in physical state of health and in angina-
related chest pain, (2) the baseline physical state of health
and in angina-related chest pain, (3) the present state of
physical health and angina-related chest pain at follow-
up, and (4) the recall of the physical state of health and
angina-related chest pain. The actual differences between
responses to global questions at baseline (e.g., ‘‘Did your
heart failure prevent you from living as you wanted to
due to pain in the chest?’’) and the matching question at fol-
low-up (‘‘Before my operation or the first time I filled out
the questionnaire, I was prevented from living as I wanted
to because of the pain in my chest’’) are given in Table 3.
Deviations from zero (which represents no recall bias)
are an indication of the recall bias magnitude. Pain in the
chest, as a single health-related event, seems to be more ac-
curately recalled than physical problems related to more
than one health-related event.
Within the structural model, serial change was estimated
through the latent variables representing the subtraction of
physical functioning and pain on the chest at baseline from
these outcomes at follow-up (i.e., present state). Recall bias
was estimated using the latent variables representing the re-
call of baseline physical health state and pain at follow-up
minus baseline. Therefore, to estimate the differences
between baseline and follow-up and between recall at fol-
low-up and the patient’s estimate of the extent of limitation
in functioning and pain in the chest at baseline, the path
coefficients were fixed at 1 and 21. A structural equation
model (SEM) was made to analyze whether retrospective
measurement of perceived magnitude of change in HRFS
may be influenced by recall bias or present-state bias. Path
coefficients were estimated using the maximum likelihood
method and represent the magnitude of the relationship be-
tween an item and a latent factor or between latent factors.
A probability (P-value) of .10 indicates that ‘‘the model’s
covariance matrix is sufficiently close to the observed data
covariance matrix for the remaining differences to be mere
sample fluctuations’’ and a root mean square error of approx-
imation (RMSEA) of .04 indicates an adequate fit of the
model [23].Table 2
Responsiveness as indicated by SRM for four measures in groups of patients differing in treatment impact and treatment effect
Treatment Angina-related chest pain
Invasive, n 5 135 Noninvasive, n 5 82 Improved, n 5 87 Stable, n 5 121 Overall, n 5 217
Physical functioning scale, SRM (95% CI)
SCS .73 (.55, .91) .29 (.09, .49) .82 (.60, 1.04) .35 (.17, .53) .56 (.42, .70)
PMC .78 (.60, .96) .12 (2.06, .30) .89 (.67, 1.11) .28 (.12, .44) .53 (.39, .67)
WPMC .75 (.57, .93) .10 (2.08, .28) .86 (.64, 1.08) .25 (.09, .41) .51 (.37, .65)
PSI .88 (.72, 1.04) .30 (.03, .57) 1.00 (.80, 1.20) .44 (.22, .66) .70 (.56, .84)
Emotional functioning scale, SRM (95% CI)
SCS .39 (.21, .57) .17 (2.05, .39) .48 (.30, .66) .14 (2.04, .32) .31 (.17, .45)
PMC .36 (.20, .52) .18 (2.06, .42) .51 (.29, .73) .13 (2.05, .31) .30 (.16, .44)
WPMC .38 (.22, .54) .19 (2.05, .43) .52 (.30, .74) .14 (2.04, .32) .31 (.17, .45)
PSI .53 (.33, .73) .32 (.07, .57) .76 (.54, .98) .21 (2.01, .43) .46 (.30, .62)
Abbreviations: CI, confidence interval; PMC, unweighted perceived magnitude of change scales; PSI, patient-specific index; SCS, serial change scales;
SRM, standardized response mean; WPMC, weighted perceived magnitude of scales.
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Fig. 2. LISREL path model of the relationship between recall bias and present-state bias and retrospectively perceived magnitude of change in physical
problems and in angina-related pain of the chest. c2 5 24.84, df 5 17, P 5 .10, root mean square error of approximation RMSEA 5 .05 (*P !.05).The model shows that the negative path coefficient
(21.57) between the magnitude of perceived change scale
(PMC) after treatment, and the extent of limitation at
follow-up (i.e., at the present state) is significantly larger
than zero. Thus, higher scores on questions enquiring into
the extent of limitation at follow-up due to angina-related
chest pain and physical problems are associated with lower
scores on perceived magnitude of change items in the same
domains, indicating a deterioration. Only a nonsignificant
relationship (.09) was found between the indicator of recall
bias and the perceived magnitude of change. There was
a significant relationship between recall of the physical
problems, pain in the chest, and baseline (.31) and no sig-
nificant relationship between these variables at the present
state (.04). Earlier results [8] were confirmed by the finding
of a significant relationship (1.74) between the indicators of
serial change and perceived magnitude of change.
4. Discussion
There are many published studies that make use of items
or global questions measuring the perceived magnitude of
change in HRFS as measurements of treatment outcome
[7,14,20,24]. In most of these studies, however, these ques-
tions are used as a single item to assess perceived change.
One of the problems with globally assessed change is that
the reliability cannot be established since Cronbach’sa cannot be computed for a single item. The serial change
scale (SCS), and the unweighted perceived magnitude of
change (PMC) scale of physical functioning had a satisfac-
tory level of internal consistency and yielded a Cronbach’s
a of .86 and .92, respectively [8].
The repeated measurement and retrospective methods
applied in the present study have various strengths and
weaknesses. The main problems with working with re-
peated measures and directly derived change scores are that
they have a significant regression effect and are prone to
Table 3
Ranked recall bias scores on pain in the chest and physical problems
Recall bias
scorea
Pain in the chest
(n 5 214), %
Physical problems






Mean recall bias score (SD)
1.03 (1.38) 1.59 (1.71)
Abbreviation: SD, standard deviation.
a Recall bias score of 0 indicates identical score on either question
(i.e., deviations from zero indicate recall bias). Scores above zero show
the magnitude of the deviation on the six-point scale. For questions and
scale, see Fig. 1. Recall bias score of 2 can thus be achieved by differing
responses of 5 vs. 3, 4 vs. 2, 3 vs. 1, or 2 vs. 0. Similarly for 3 (5 vs. 2, 4 vs.
1, 3 vs. 0), 4 (5 vs. 1, 4 vs. 0), and 5 (5 vs. 0).
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repeated measurement may also be flawed by floor and
ceiling effects [28,29]dfor example, carryover effects of
learning if the retest intervals are too short, or because of
specific events occurring between the first and second mea-
surement, the natural course of the disease, or acquiescence
and social desirability [30].
Another threat to the validity of change scores is the
assumption made by researchers that subjects have an
internalized perception of their level of functioning with
regard to, for example, the domain of physical health status,
and that this internalized standard will not change between
baseline and post-test. Respondents in the present study
may also have recalibrated their baseline situation due to
the clinical intervention. For example, because of their high
hopes for a better physical state of health they may have felt
inclined to give socially desirable answers to health profes-
sionals, or they may have changed the anchors for their rat-
ings over time due to significant and substantial changes in
the course of the disease. These confounding factors are
associated with what is called response shift [29,31,32].
There are also several threats to the reliability and valid-
ity of our findings based on the use of multitransition items
in the present study. Retrospective perception of change
may not be accurate, due to recall bias, and patients may
equate their present state with a change in their health
status. A respondent doing poorly after treatment may be
inclined to think that in general things are getting worse,
even with improved or unchanged health state [9,14,24].
In the study by Fitzpatrick et al. [33], however, the transi-
tion questions were shown not to be determined by the
patient’s mood at post-test nor by the present state.
Patients in the present study who suffered a significant
decline in health due to invasive treatment such as CABG
of PTCA may also have overestimated their perception of
baseline health if they were longing for the time when their
health was better [14,29]. We decided to use a short time
interval, because inaccurate recall seems to be determined
by a lengthy time interval, exposure or intervention, and
by the degree of detail required [34].
The significance, the vividness, and meaningfulness of
events also contribute to a more accurate recall, and this
was the case in the present study. Some of the findings pub-
lished by Aseltine et al. [14] suggest that their measures
assessing more concrete aspects of a patient’s condition
provided greater correspondence between prospective and
retrospective assessment than the more abstract measures
of general health. Despite the limitations of transition ques-
tions, there is a growing realization that patients can be
more directly involved in judging for themselves whether
treatments have improved their health status in relation to
the observed health status of other patients by directly
asked transition questions [28,33,35–37]. Moreover, transi-
tion questions were shown to be more sensitive to changes
over time in health-related quality of life than change
scores [1,2,6].Central to our analysis was the assumption that the
multi-item transition indices (scales) measure magnitude
of change similar to that estimated with the serially as-
sessed change in domains of health to which they were
paired. In several studies, the agreement between retrospec-
tive assessments and serial assessments was poor if single
items were used. The results of the present study therefore
argue for multi-item batteries of transition items, because
single-item transition questions do not cover a representa-
tive sample of the health aspects that belong to the under-
lying construct or dimension. Further studies should be
conducted to address the psychometric aspects of transition
scales used repeatedly in longitudinal studies, such as test–
retest reliability or the ability to discriminate between
known groups.
The retrospective judgment of change is difficult. Pa-
tients must be able to quantify both their present state and
their state at baseline and then perform a mental subtraction.
There is evidence that patients are in fact unable to remem-
ber their initial state, and that the judgment is based on an
implicit theory of change beginning with their present state
and working backwards [24]. This typically results in a high
positive correlation between the retrospective scores and the
present state, and a correlation near zero between the retro-
spective scores and the baseline measure.
The correlation between the present-state questions and
concordant transition questions seems logical in a sample
of patients who underwent treatment with a known efficacy.
In the present study, it was expected that a perceived im-
provement in, for example, climbing stairs should correlate
with no limitations in climbing stairs after PTCA or CABG,
because these treatments aim to improve the physical con-
dition of climbing stairs. Patients first completed the pres-
ent-state questionnaire, which was followed by questions
on retrospectively perceived change. To control for pres-
ent-state bias, patients should be randomly assigned to re-
peated measurement or serial prospective measurement of
change or to retrospective measurement with transition
questions.
In the present study, it was assumed that the scores on
outcome measures at baseline may have been affected in
patients with knowledge of the treatment plan or who are
scheduled on a waiting list for CABG or PTCA compared
with patients who had no knowledge of what was going to
happen. Due to logistical problems, only 67 patients were
blinded with regard to the plan of treatment. It was ex-
pected that patient who were blinded would have lower
psychological stress, in particular those who underwent
an invasive treatment. Baseline scores on the emotional
functioning scale of these 67 patients (mean 5 69.7,
SD 5 25.2) did not differ significantly from the 250 pa-
tients who were not blinded (mean 5 63.3, SD 5 27.6),
with a 95% CI from 213.7 to 0.94. We therefore do not ex-
pect that patients knowingly going for invasive treatment
will experience a different change in emotional functioning
from those who go blinded into it.
511B. Middel et al. / Journal of Clinical Epidemiology 59 (2006) 503–511To our knowledge, no other studies have used a set of
PMC or WPMC transition items to measure change in do-
mains of health such as physical functioning or emotional
functioning. Despite the shortcomings of the present study,
we believe that it is important for further research. The use
of sets of multiple-item transition scales to measure change
in health domains provides an opportunity for an unequiv-
ocal representation of changes that are relevant for the pa-
tient. This method may also be considered in study designs
where repeated measurement is not feasible, such as in the
assessment of change in patients who have had an acute
heart attack after emergency referral to a hospital.
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